Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use

Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use

US Patent 7759366 · Granted Jul 20, 2010

Estimated economic value: $11,797,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Exendin-4 derivatives as dual GLP1/glucagon agonists2020
Functionalized Exendin-4 derivatives2019
Exendin-4 derivatives as selective glucagon receptor agonists2018
Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obes2018
Substituted indanone compounds as GPR119 modulators for the treatment of diabete2018
Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists2017
Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists2017
Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-42017
Substituted fused heterocycles as GPR119 modulators for the treatment of diabete2017
Dual GLP-1/glucagon receptor agonists derived from exendin-42017
Non-acylated exendin-4 peptide analogues2017
Dual GLP-1/GIP receptor agonists2017